Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Multiple Sclerosis

  Free Subscription


12.01.2026

1 AJNR Am J Neuroradiol
2 Ann Neurol
1 BMC Neurol
1 Brain
2 J Neuroimmunol
1 J Neurol Neurosurg Psychiatry


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. MUNSCH F, Ravache A, Yamamoto T, Zhang B, et al
    Enhanced Spinal Cord Lesion Detection in MS Using White-Matter-Nulled 3D MPRAGE with Deep Learning Reconstruction.
    AJNR Am J Neuroradiol. 2026;47:225-233.
    PubMed         Abstract available


    Ann Neurol

  2. SMITH C, Greenberg BM, Reynolds J, Mosavi-Hecht R, et al
    A Patient-Derived Antibody Ameliorates Disease Severity in a Relapsing Remitting Murine Model of Multiple Sclerosis.
    Ann Neurol. 2026 Jan 10. doi: 10.1002/ana.78149.
    PubMed         Abstract available

  3. CORSTEN CEA, Marques AM, Vinke EJ, de Mol CL, et al
    Brain Atrophy Associated With Risk Variant rs10191329 Extends Beyond Multiple Sclerosis.
    Ann Neurol. 2026 Jan 5. doi: 10.1002/ana.78148.
    PubMed         Abstract available


    BMC Neurol

  4. SKACIK P, Kotulova L, Kantorova E, Kurca E, et al
    Positional nystagmus in multiple sclerosis: a cross-sectional case-control study.
    BMC Neurol. 2026 Jan 5. doi: 10.1186/s12883-025-04597.
    PubMed        


    Brain

  5. VILLAR LM
    The CD5-CK2-STAT3 axis in Th17 cell polarization: implications for multiple sclerosis.
    Brain. 2026;149:9-10.
    PubMed        


    J Neuroimmunol

  6. ALEXAKI A, Baltoumas F, Tzanetakos D, Zografou C, et al
    B cell tolerance checkpoint function in multiple sclerosis and transient CD52 depletion.
    J Neuroimmunol. 2026;413:578854.
    PubMed         Abstract available

  7. ABDELGAIED MY, Abdelgawad O, Rashad MH, Solayman MH, et al
    Efficacy and tolerability of metformin as an adjuvant therapy in patients with relapse-remitting multiple sclerosis receiving interferon Beta 1a: A randomized pilot trial.
    J Neuroimmunol. 2025;412:578852.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  8. JACQUES K, Race J, Goyne C, Fair A, et al
    Telomere length as a marker of biological age in paediatric multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2026 Jan 7:jnnp-2025-336736.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.